COGNICURRENT

South Africa aims to locally produce Lenacapavir, a revolutionary preventive treatment for HIV, which has just begun to be administered on the continent.

Thousands of Americans are losing access to HIV treatment as nearly 20 states impose restrictions on assistance programs.

Families of victims of the infected blood scandal have criticized the UK government for creating a compensation scheme that penalizes them for the deaths of their loved ones.

South Africa is aiming to produce the HIV prevention drug lenacapavir locally to enhance treatment access and support its pharmaceutical sector.

NAFDAC has issued a warning about counterfeit HIV test kits circulating in Nigeria, urging the public and healthcare providers to be vigilant.

The Nigerian Federal Executive Council has approved N9.99 billion for the procurement of HIV antiretroviral drugs and the upgrade of cancer treatment facilities.

NAFDAC has issued a safety alert regarding malaria and HIV test kits from Meril Diagnostics Pvt. Ltd due to significant violations found in an audit by the WHO.

The fight against HIV in Ukraine faces severe challenges due to the ongoing war, resulting in unreliable infection statistics and a potential undercounting of cases.

Nigeria is set to receive Lenacapavir, a significant HIV prevention injection, in March, which has shown 100% efficacy in clinical trials.

Municipal pharmacies in Piracicaba, Brazil are now providing free HIV self-testing, following a new initiative from the local health department.

Nigeria is set to receive a new HIV prevention injection called Lenacapavir in March 2026 as part of efforts to reduce new infections.

The International Zero Discrimination Day on March 1st highlights the ongoing fight against various forms of discrimination worldwide, initially focusing on HIV/AIDS-related stigma and now encompassing broader issues of inequality.

March 1 is recognized as Zero Discrimination Day, promoting awareness and rights for individuals living with HIV/AIDS, as proclaimed by the United Nations.

A new daily single-dose pill for HIV treatment, BIC/LEN, has shown promise in clinical trials, simplifying the lives of long-term HIV patients.

Bashir Lukonge, known as Bash Luks, is gaining prominence in Uganda's entertainment scene by blending music, film, and advocacy for HIV awareness.

Denmark has become the first country in the world to eliminate mother-to-child transmission of HIV and syphilis according to the World Health Organization.

Kenya has begun providing lenacapavir, a long-acting injectable HIV prevention drug, free of charge to eligible patients, marking a significant advancement in the fight against HIV.

A recent webinar addressed the ethical and scientific considerations in pediatric HIV cure research, highlighting the role of people living with HIV in this field.

The article emphasizes the importance of trust and clear communication in HIV cure research to combat misinformation and build community engagement in South Africa.

The article discusses the significance of involving people living with HIV in the research for a cure, particularly in children, amidst ongoing challenges and ethical considerations.

Kenya has launched the use of a new injectable preventive treatment against HIV called lenacapavir, marking a significant advance in HIV prevention methods.

A new once-daily HIV drug could simplify treatment for elderly patients who have been managing the virus for decades.

Eduardo Casanova shares his experience of living with HIV and the stigma associated with it while promoting his documentary 'Sidosa.'

Kenya has started administering LENACAPAVIR, a revolutionary long-acting HIV prevention drug, marking a significant step in the fight against HIV/AIDS.

A long-anticipated preventive HIV treatment, cabotegravir, is set to be available in France, fully covered by health insurance.

Kenya has begun administering lenacapavir, a new HIV prevention drug, as part of its efforts to combat the HIV epidemic.

Kenya has launched a new twice-yearly HIV prevention injection in a Nairobi slum, significantly enhancing the fight against HIV transmission.

Local organizations in Zimbabwe are alarmed about potential disruptions to HIV treatment following the collapse of funding negotiations with the U.S.

Alice shares her journey of fighting for justice in Latvia after being knowingly infected with HIV by a partner, highlighting the impact on her life and the social stigma she faces.

New research suggests that a single daily pill combining two medications may effectively substitute more complex HIV treatments.

Zimbabwe has withdrawn from negotiations for a $367 million health aid deal with the US due to concerns over national sovereignty and control over health data.

U.S. Ambassador Pamela Tremont expressed disappointment over the Zimbabwean government's refusal of a vital $367 million health fund aimed at combating HIV/AIDS.

A library in Porto Alegre pays tribute to iconic Brazilian author Caio Fernando Abreu 30 years after his death by showcasing his works.

A significant number of former prisoners in Queensland may have been exposed to HIV and hepatitis C following the sharing of needles by an infected inmate.

Zimbabwe has started administering lenacapavir, a long-acting HIV prevention drug, aimed at significantly reducing infections among high-risk groups.

The Ecuadorian Institute of Social Security (IESS) has distributed antiretroviral medications to healthcare facilities nationwide to ensure the continuity of HIV treatments.

The US will support 271,000 Zimbabweans in accessing a new biannual HIV prevention injection as part of a campaign to combat the disease.

Zimbabwe has launched a national program for Lenacapavir, a twice-yearly injectable HIV prevention drug, marking a significant step in its fight against AIDS.

In the aftermath of Carnival, Teresina emphasizes the need for free testing for HIV and other STIs at local health facilities.

The article discusses the urgent need to streamline funding for South Africa's district health system, emphasizing the potential benefits of proposed healthcare reforms.

Kenya will introduce a new HIV-prevention drug, Lenacapavir, in March, significantly reducing transmission risks.

Kenya is set to launch a new HIV prevention drug, lenacapavir, in March, which has proven to reduce the risk of HIV transmission significantly.

Kenya has received 21,000 doses of the long-acting injectable HIV prevention drug Lenacapavir, set to be rolled out across the country starting March 2026.

The arrest of 12 men in Senegal under punitive anti-LGBT laws has raised alarm over the ongoing criminalization of same-sex relations and the implications for people living with HIV.

Nigeria has made strides in HIV testing capabilities by locally packaging a WHO-approved rapid diagnostic test, enhancing its public health infrastructure.

The Carnaval in Baixada Santista will include campaigns aimed at preventing sexually transmitted infections by distributing condoms and HIV self-test kits.

In 2025, Mato Grosso has reported over 900 HIV cases, prompting health authorities to intensify awareness and prevention efforts for sexually transmitted infections during Carnival.

Ellie Harrison, diagnosed with HIV at 21, shares her struggle with stigma and her journey towards advocacy.

The article discusses the stigma surrounding HIV and recent controversial statements made by media personality Mariló Montero regarding the transmission of sexually transmitted infections (STIs).

Global condom purchases have decreased by 30%, while promotional campaigns for their use have been cut in half, according to civil organizations on International Condom Day.